Related Experiment Video
Updated: May 24, 2025

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Why think twice before prescribing proton pump inhibitors
An-Sofie Lemmens1,2, Koen Huysentruyt1, Yvan Vandenplas3
1Department of Pediatric Gastroenterology, UZ Brussels, KidZ Health Castle, Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090, Brussels, Belgium.
Proton pump inhibitors (PPIs) are widely prescribed for acid-related issues. This review details common adverse effects of PPIs on the gastric mucosa, impacting gut microbiota and immune response.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Proton pump inhibitors (PPIs) are frequently prescribed for acid-related disorders due to their efficacy.
- Their mechanism of action and metabolism lead to a wide range of reported adverse effects.
- Despite their success, insufficient attention is given to the multiple adverse effects associated with PPIs.
Purpose of the Study:
- To review the most common adverse effects of proton pump inhibitors (PPIs) specifically on the gastric mucosa.
- To highlight the impact of PPIs on gastric pH and the gastric mucosal environment.
Main Methods:
- This is a review article, synthesizing existing literature on PPIs and their adverse effects.
- Focus is placed on studies examining the impact of PPIs on the gastric mucosa.
Main Results:
- PPIs directly alter gastric pH, influencing the gastric mucosa.
- Adverse effects on the gastric mucosa are common and varied.
- PPIs alter the composition of gut and gastric microbiota.
Conclusions:
- Proton pump inhibitors (PPIs) significantly affect gastric and gut microbiota composition.
- These alterations in microbiota can modulate the host's immune response.
- Further well-designed prospective trials are needed to accurately assess PPI adverse effects.
More Related Videos
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...